CVRx, Inc. (CVRX)Healthcare | Medical Devices | Minneapolis, United States | NasdaqGS
7.34 USD
+0.10
(1.381%)
⇧
(April 21, 2026, 3:18 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:55 p.m. EDT
Despite positive news regarding Medicare approval and Q1 growth, the intraday data reveals a 'hidden long' narrative where speculators are aggressively hedging for a breach of the $7.50-$8.80 range. With a 52-week high of $11.30 and the stock trading at $7.36 approaching technical resistance (fifty-day avg $7.63), the massive December put flow suggests a countertrend bet on a strategic capitulation rather than a bullish breakout. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.120443 |
| AutoARIMA | 0.121671 |
| AutoETS | 0.121671 |
| AutoTheta | 0.139410 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 60% |
| H-stat | 0.34 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.005 |
| Excess Kurtosis | 1.03 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 128.43 |
| Revenue per Share | 2.172 |
| Market Cap | 193,127,200 |
| Forward P/E | -3.93 |
| Beta | 1.12 |
| Profit Margins | -94.10% |
| Website | https://www.cvrx.com |
As of April 18, 2026, 11:55 p.m. EDT: Options activity is characterized by asymmetric positioning. In the short term (May/July), calls show a slight lean towards $12.50 OTM, but near-term (Oct) pricing is virtually flat. The significant signal emerges at the December 18 expiration: massive long put open interest (255 contracts: 119 at $5.00, 39 at $7.50, 106 at $7.50) combined with a distribution increase of +1.9% at the ATM strike, whereas call activity in December is significantly lower. This structure indicates aggressive speculative positioning for downside protection or a target price test near $7.50.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.20066333 |
| Address1 | 9,201 West Broadway Avenue |
| Address2 | Suite 650 |
| All Time High | 33.135 |
| All Time Low | 4.299 |
| Ask | 9.06 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 319,140 |
| Average Daily Volume3 Month | 348,621 |
| Average Volume | 348,621 |
| Average Volume10Days | 319,140 |
| Beta | 1.124 |
| Bid | 5.53 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | 1.495 |
| City | Minneapolis |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.34 |
| Current Ratio | 7.633 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 7.84 |
| Day Low | 7.0 |
| Debt To Equity | 128.43 |
| Display Name | CVRx |
| Earnings Call Timestamp End | 1,770,931,800 |
| Earnings Call Timestamp Start | 1,770,931,800 |
| Earnings Timestamp | 1,770,930,000 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -50,509,000 |
| Ebitda Margins | -0.89158 |
| Enterprise To Ebitda | -3.273 |
| Enterprise To Revenue | 2.918 |
| Enterprise Value | 165,292,032 |
| Eps Current Year | -1.97648 |
| Eps Forward | -1.86873 |
| Eps Trailing Twelve Months | -2.04 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 763 416 2841 |
| Fifty Day Average | 7.6567 |
| Fifty Day Average Change | -0.31669998 |
| Fifty Day Average Change Percent | -0.041362464 |
| Fifty Two Week Change Percent | 20.066334 |
| Fifty Two Week High | 11.3 |
| Fifty Two Week High Change | -3.96 |
| Fifty Two Week High Change Percent | -0.35044247 |
| Fifty Two Week Low | 4.299 |
| Fifty Two Week Low Change | 3.0410004 |
| Fifty Two Week Low Change Percent | 0.7073739 |
| Fifty Two Week Range | 4.299 - 11.3 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,625,059,800,000 |
| Float Shares | 18,165,007 |
| Forward Eps | -1.86873 |
| Forward P E | -3.9278014 |
| Free Cashflow | -23,787,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 223 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.85329 |
| Gross Profits | 48,340,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09349 |
| Held Percent Institutions | 0.66084 |
| Implied Shares Outstanding | 26,311,607 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-06-30 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. |
| Long Name | CVRx, Inc. |
| Market | us_market |
| Market Cap | 193,127,200 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1380491 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -53,306,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 190,496,034 |
| Number Of Analyst Opinions | 6 |
| Open | 7.29 |
| Operating Cashflow | -40,170,000 |
| Operating Margins | -0.69795 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 763 416 2840 |
| Previous Close | 7.24 |
| Price Eps Current Year | -3.7136729 |
| Price Hint | 2 |
| Price To Book | 4.909699 |
| Price To Sales Trailing12 Months | 3.4090695 |
| Profit Margins | -0.94095004 |
| Quick Ratio | 6.486 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.57143 |
| Region | US |
| Regular Market Change | 0.10000038 |
| Regular Market Change Percent | 1.3812208 |
| Regular Market Day High | 7.84 |
| Regular Market Day Low | 7.0 |
| Regular Market Day Range | 7.0 - 7.84 |
| Regular Market Open | 7.29 |
| Regular Market Previous Close | 7.24 |
| Regular Market Price | 7.34 |
| Regular Market Time | 1,776,799,102 |
| Regular Market Volume | 370,493 |
| Return On Assets | -0.26900998 |
| Return On Equity | -0.96586996 |
| Revenue Growth | 0.044 |
| Revenue Per Share | 2.172 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 26,311,607 |
| Shares Percent Shares Out | 0.0643 |
| Shares Short | 1,692,878 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,932,071 |
| Short Name | CVRx, Inc. |
| Short Percent Of Float | 0.086899996 |
| Short Ratio | 7.39 |
| Source Interval | 15 |
| State | MN |
| Symbol | CVRX |
| Target High Price | 14.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 11.16667 |
| Target Median Price | 12.0 |
| Total Cash | 75,708,000 |
| Total Cash Per Share | 2.877 |
| Total Debt | 50,504,000 |
| Total Revenue | 56,651,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.010775 |
| Two Hundred Day Average Change | -0.67077446 |
| Two Hundred Day Average Change Percent | -0.083734035 |
| Type Disp | Equity |
| Volume | 370,493 |
| Website | https://www.cvrx.com |
| Zip | 55,445 |